Aquestive Therapeutics (AQST) Change in Inventory (2017 - 2026)

Aquestive Therapeutics' Change in Inventory history runs 10 years deep, the most recent figure standing at $1.9 million for Q1 2026.

• In Q1 2026, Change in Inventory rose 64.3% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $868000.0 (up 261.94% YoY), while the FY2025 annual figure was $126000.0, up 117.38% from the prior year.
• Change in Inventory was $1.9 million for Q1 2026 at Aquestive Therapeutics, up from -$1.7 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $1.9 million in Q1 2026 to a low of -$1.7 million in Q4 2025.
• Historically, Change in Inventory has averaged $237000.0 across 5 years, with a median of $379000.0 in 2022.
• The sharpest annual moves came in 2022 and 2025: Change in Inventory surged 7054.17% in 2022, then slumped 538.18% in 2025.
• A 5-year view of Change in Inventory shows it stood at -$944000.0 in 2022, then soared by 67.16% to -$310000.0 in 2023, then sank by 215.16% to -$977000.0 in 2024, then sank by 75.44% to -$1.7 million in 2025, then surged by 210.62% to $1.9 million in 2026.
• The last three Change in Inventory figures came in at $1.9 million (Q1 2026), -$1.7 million (Q4 2025), and -$241000.0 (Q3 2025), per Business Quant data.